Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.Cmvv_fHs.js ...

Kohl’s Corp (NYSE:KSS) shares are trading lower after the company reported third-quarter earnings. The company reported a net ...

Kohl's shares are sinking in premarket trading after the department store chain reported weaker-than-expected results and lowered its guidance, and said that chief executive Tom Kingsbury is stepping ...

Kohl's on Tuesday forecast a bigger drop in annual sales than previously expected, a sign the department-store chain is ...

Ashley Buchanan, CEO of Michaels Companies will become the new CEO on Jan. 15, Kohl’s announced. He has been CEO of Michaels ...

Kohl’s saw sales decline in the latest quarter while its revised outlook for the year suggested a challenging upcoming ...

Kohl's reported disappointing Q3 earnings as sales in key segments lagged expectations, prompting a downward revision of its ...

Stock futures are higher Tuesday morning as investors digest earnings reports from several retailers and await results from ...

Kohl’s Corporation is reporting that company CEO Tom Kingsbury plans to step down as CEO, effective January 15, 2025. He will ...

Kohl’s Corporation’s outgoing CEO Tom Kingsbury said in a Tuesday media release that third quarter results did not meet ...

Kohl’s (KSS) slid over -4% in pre-market trading after the company said in a statement that CEO Tom Kingsbury will resign effective January 15th, 2025. Chevron (CVX) gained more than +1% in pre-market ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal.